Neptune is also pleased to announce that Toni Rinow, Ph.D., MBA, has joined the team. She will be responsible for Investors Relations and Corporate Development. "Dr. Rinow, former Senior V.P., Fonds de Solidarite, will be an important asset to the company because of her experience in the capital markets, especially with life science companies. We believe that, because of her knowledge, reputation and networking contacts, Dr. Rinow will be able to bring market value recognition to Neptune," stated Mr. Henri Harland, President and Chief Executive Officer.
Neptune would also like to inform its shareholders that since its shares are listed on NASDAQ, it will be filing its quarterly and annual results respectively, not more than 45 days and 90 days after the applicable period as compared to not more than 60 and 120 days previously.
About Neptune Technologies & Bioressources, Inc.
Neptune Technologies & Bioressources Inc. develops proprietary and potent health ingredients from underexploited marine biomasses, such as krill, with its patented extraction process (Neptune OceanExtract(TM)). Using its proprietary process, Neptune Technologies & Bioressources Inc. is strategically positioning itself in the health and wellness market.
Natural biomass extraction is now playing an important role in developing nutrigenomics, the next wave in nutritional research. Through strategic alliances and partnerships, as well as through clinical studies, the Company continues to demonstrate the immense beneficial effects of these products. The Company develops and markets new formulas and new products for specific applications in high growth markets such as the nutraceutical, cosmeceutical, biopharmaceutical and nutrigenomics markets.
NASDAQ and TSX
|SOURCE NEPTUNE TECHNOLOGIES & BIORESSOURCES INC.|
Copyright©2007 PR Newswire.
All rights reserved